rs779647460
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_004380.3(CREBBP):c.6618_6620dupGCA(p.Gln2207dup) variant causes a disruptive inframe insertion change. The variant allele was found at a frequency of 0.0000298 in 1,612,288 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004380.3 disruptive_inframe_insertion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CREBBP | NM_004380.3 | c.6618_6620dupGCA | p.Gln2207dup | disruptive_inframe_insertion | Exon 31 of 31 | ENST00000262367.10 | NP_004371.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CREBBP | ENST00000262367.10 | c.6618_6620dupGCA | p.Gln2207dup | disruptive_inframe_insertion | Exon 31 of 31 | 1 | NM_004380.3 | ENSP00000262367.5 | ||
CREBBP | ENST00000382070.7 | c.6504_6506dupGCA | p.Gln2169dup | disruptive_inframe_insertion | Exon 30 of 30 | 1 | ENSP00000371502.3 |
Frequencies
GnomAD3 genomes AF: 0.000185 AC: 28AN: 151718Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000367 AC: 9AN: 245396Hom.: 0 AF XY: 0.0000300 AC XY: 4AN XY: 133306
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1460570Hom.: 0 Cov.: 33 AF XY: 0.0000138 AC XY: 10AN XY: 726584
GnomAD4 genome AF: 0.000185 AC: 28AN: 151718Hom.: 0 Cov.: 32 AF XY: 0.000189 AC XY: 14AN XY: 74128
ClinVar
Submissions by phenotype
not specified Benign:2
- -
- -
Rubinstein-Taybi syndrome Uncertain:1
This variant, c.6618_6620dup, results in the insertion of 1 amino acid(s) of the CREBBP protein (p.Gln2216dup), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with CREBBP-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Rubinstein-Taybi syndrome due to CREBBP mutations;C5193034:Menke-Hennekam syndrome 1 Benign:1
- -
CREBBP-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at